Epidemiological significance of genome variations in Pseudomonas aeruginosa causing chronic lung infection in patients with cystic fibrosis

Epidemiological significance of genome variations in Pseudomonas aeruginosa causing chronic lung infection in patients with cystic fibrosis

Objective. To present the data on the main mechanism of molecular variation in P. aeruginosa causing chronic lung infection in patients with cystic fibrosis. Materials and Methods. A total of 1800 throat swabs and sputum samples from cystic fibrosis patients were included in the study over the 1...

Full description

Bibliographic Details
Main Authors:	Shaginyan I.A., Avetisyan L.R., Chernukha M.Yu., Siyanova E.A., Burmistrov E.M., Voronkova A.Yu., Kondratieva E.I., Chuchalin A.G., Gintzburg A.L.
Format:	Article
Language:	Russian
Published:	Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy 2019-12-01
Series:	Клиническая микробиология и антимикробная химиотерапия
Subjects:	chronic lung infection p. aeruginosa whole genome sequencing variation mutations
Online Access:	https://cmac-journal.ru/publication/2019/4/cmac-2019-t21-n4-p340/cmac-2019-t21-n4-p340.pdf

Similar Items

Use of the MALDI Biotyper system and the microbiological diagnosis algorithm for identification of non-fermenting bacteria isolated from respiratory tract in cystic fibrosis patients
by: Chernukha M.Yu., et al.
Published: (2017-11-01)

Directions of Epidemiological Surveillance of Chronic Lung Infections Caused by <i>Burkholderia cepacia Complex</i>, <i>Achromobacter spp., Pseudomonas aeruginosa</i> and Methicillin-Resistant <i>Staphylococcus aureus</i> in Patients with Cystic Fibrosis
by: L. R. Avetisyan, et al.
Published: (2020-03-01)

Epidemiological Features of Chronic Lung Infection in Patients with Cystic Fibrosis
by: I. A. Shaginyan, et al.
Published: (2017-12-01)

NTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)
by: L. R Avetisyan, et al.
Published: (2015-12-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

CD14 C-159T and early infection with <it>Pseudomonas aeruginosa </it>in children with cystic fibrosis
by: Sly PD, et al.
Published: (2005-06-01)

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients
by: Soltan Dallal, MM, et al.
Published: (2015-01-01)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis
by: Courtney E. Chandler, et al.
Published: (2023-08-01)

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates
by: Valerio eIebba, et al.
Published: (2014-06-01)

The In-Vitro Activity of Some Antipseudomonal Antibiotics Against Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
by: Burçin ŞENER, et al.
Published: (1998-06-01)

Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis
by: Catherine R. Armbruster, et al.
Published: (2021-10-01)

Pseudomonas aeruginosa: the history of one of the most successful nosocomial pathogens in Russian hospitals
by: Skleenova E.Yu., et al.
Published: (2018-08-01)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum
by: Laura eLine, et al.
Published: (2014-10-01)

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm
by: Arianna ePompilio, et al.
Published: (2015-09-01)

Pseudomonas aeruginosa in the etiology of infections in hospitalized patients
by: Lyamin A.V., et al.
Published: (2018-11-01)

Dual characteristics of Bellamya aeruginosa encountering Microcystis aeruginosa: Algal control and toxin depuration
by: Min Wang, et al.
Published: (2023-03-01)

ANTIBIOTIC RESISTANCE OF PSEUDOMONAS AERUGINOSA STRAINS WITH DIFFERENT PIGMENT PRODUCTION ABILITY
by: O. S. Zhdanova, et al.
Published: (2016-02-01)

Features of the course and eradication of multidrug-resistant Pseudomonas aeruginosa infection in cystic fibrosis: clinical case
by: E. I. Kondratyeva, et al.
Published: (2021-10-01)

Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01)

THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01)

INHIBITION OF GROWTH OF BACTERIA IN STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA CULTURES BY COPPER AND ZINC CATIONS, APPLIED AT PHYSIOLOGICAL CONCENTRATIONS
by: S. B. Cheknev, et al.
Published: (2016-06-01)

INHIBITION OF GROWTH OF BACTERIA IN STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA CULTURES BY COPPER AND ZINC CATIONS, APPLIED AT PHYSIOLOGICAL CONCENTRATIONS
by: S. B. Cheknev, et al.
Published: (2016-06-01)

New mutations in genes associated with cefiderocol resistance in a clinical isolate of Pseudomonas aeruginosa
by: Bocharova Yu.A., et al.
Published: (2023-12-01)

Pseudomonas aeruginosa: Pathogenicity, Pathogenesis and Diseases
by: Lazareva A.V., et al.
Published: (2015-08-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

Tipificación molecular de aislamientos de Pseudomonas aeruginosa obtenidos de pacientes con fibrosis quística Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
by: N. G. Iglesias, et al.
Published: (2008-03-01)

Antimicrobial resistance of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014
by: Edelstein M.V., et al.
Published: (2017-02-01)

DECELERATION OF BACTERIAL GROWTH IN STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA CULTURES IN THE PRESENCE OF COPPER AND ZINC CATIONS
by: S. B Cheknev, et al.
Published: (2015-04-01)

Mechanisms and regulation of antimicrobial resistance in Pseudomonas aeruginosa
by: Chebotar I.V., et al.
Published: (2017-11-01)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01)

EVALUATION OF BIOLOGICAL PROPERTIES OF PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM PATIENTS WITH STERNUM AND RIB OSTEOMYELITIS
by: A. V Kasatov, et al.
Published: (2015-04-01)

Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients
by: Jashanpreet eKaur, et al.
Published: (2015-08-01)

Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
by: Sener Okur D, et al.
Published: (2019-03-01)

Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran
by: Hossein Fazeli, et al.
Published: (2013-01-01)

Italian national survey on molecular epidemiology of Pseudomonas aeruginosa from pulmonary infection of Cystic Fibrosis patients
by: Graziana Manno, et al.
Published: (2011-06-01)

Emergence of Pseudomonas aeruginosa cross-infection in children with cystic fibrosis attending an Iranian referral pediatric center
by: M Ghazi, et al.
Published: (2012-09-01)

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
by: Anna S. Tai, et al.
Published: (2017-11-01)

Antimicrobial activity of tobramycin against Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
by: P. Perenovska, et al.
Published: (2016-03-01)